How to Get Rid of Man Boobs: Chest Fat vs Gynecomastia, Evidence Review

“Man boobs” are one of two different things, and which one you have decides what works. Often it is simply chest fat — pseudogynecomastia — and a breast-clinic review names obesity, which adds fat rather than gland, as the major cause of male breast enlargement^[1]. True gynecomastia is growth of the breast gland itself, driven by the balance between estrogen and androgens, and it is remarkably common: 32% to 65% of men have some, depending on age and how it is defined^[2]. Fat comes off with overall weight loss. Gland tissue that has been there for about a year does not — it turns fibrous, and non-surgical treatment can’t remove it^[3]. Chest workouts build the muscle underneath but don’t burn the fat on top. The medical options — treating the cause, waiting, tamoxifen in selected recent cases, or surgery — depend on which tissue you have and how long it has been there. A clinician’s exam, not the mirror, tells them apart.

The short answer

• Two different tissues. Gynecomastia is a benign growth of male breast gland tissue^[2]. Pseudogynecomastia is extra fat on the chest with no enlargement of the gland underneath^[1].
• Common, and often temporary. About half of mid-pubertal boys develop some, and more than 90% of those cases resolve within 24 months; in adults it grows more common with age^[2].
• Weight loss shrinks fat, not established gland. Gland tissue turns fibrous within about 12 months and then can’t be removed without surgery^[3].
• Chest exercise doesn’t target chest fat. In an MRI study of people who trained only one arm, fat loss was body-wide rather than local^[4]. One small trial found a modest local effect in the abdomen^[5] — and gland tissue isn’t fat, so exercise can’t burn it off.
• Drugs are for selected, recent cases. The European Academy of Andrology advises against tamoxifen-type drugs in general^[2]; a 2026 Italian guideline allows them for selected painful or unexplained cases^[6]. Surgery is the treatment for long-standing gynecomastia^[2].
• Know the red flags. A distinct lump, nipple discharge or distortion, or one-sided enlargement warrants prompt evaluation^[1]. Male breast cancer is under 1% of all breast cancers — rare, but real^[7].

Chest fat or breast gland: two different problems

An adult man’s breast is made of fat, supporting tissue, and a vestigial duct system behind the nipple^[1]. True gynecomastia means that gland has grown — a “benign proliferation of glandular tissue,” in the European Academy of Andrology’s definition^[2]. Pseudogynecomastia (also called lipomastia) is excess fat under the skin of the chest “without any enlargement of the underlying mammary glandular tissue”^[1].

In a German clinic study of 124 pubertal boys with breast enlargement, ultrasound separated 86 cases of true gynecomastia from 38 of pseudogynecomastia — and the two groups had different hormones. Boys with glandular growth had a higher estradiol-to-testosterone ratio and lower testosterone than boys whose enlargement was fat, or than boys without enlargement^[8]. Fat is a body-composition problem. Gland is a hormone-balance problem.

What causes gynecomastia

The common thread: estrogen versus androgens

Breast gland tissue responds to hormones: gynecomastia results when estrogen action at the breast outweighs androgen action^[9]. A key player is aromatase, the enzyme that converts androgens into estrogens. Increased aromatase activity is important in the gynecomastia seen with obesity, aging, and puberty, as well as with liver disease, an overactive thyroid, Klinefelter syndrome, and tumors of the testes, adrenal glands, and liver^[9].

Puberty

Pubertal gynecomastia affects roughly half of boys in mid-puberty, and more than 90% of cases resolve on their own within 24 months^[2]. For a teenager, the first step is usually time, not treatment.

Body fat

Extra body fat works through two routes at once. It adds fat to the chest directly, and it raises aromatase-driven estrogen production, which can stimulate the gland^[9]. In 954 healthy young men aged 18 to 26 examined at an Athens army hospital, 40.5% had more than 2 cm of breast tissue, and those men weighed about 10 kg more on average than those without it (79.7 kg vs 69.1 kg)^[10]. The same aromatase pathway is why excess fat lowers testosterone in men — see how weight affects testosterone and fertility.

Aging and underlying conditions

Gynecomastia becomes more common as men age, and when an adult is properly evaluated, an underlying cause turns up in about 45% to 50% of cases^[2]. The guideline also recommends a full workup even when an obvious explanation, such as a medication, is present^[2].

Medications

Drugs account for an estimated 10% to 25% of gynecomastia cases^[11]. An evidence-graded review found good evidence linking spironolactone, cimetidine, ketoconazole, growth hormone, estrogens, hCG, anti-androgens, GnRH analogs, and 5-alpha reductase inhibitors (the finasteride and dutasteride class) to gynecomastia. It classed risperidone, verapamil, nifedipine, omeprazole, some HIV medications, anabolic steroids, alcohol, and opioids as probable causes^[11]. If one of these is on your list, don’t stop it on your own — ask the prescriber whether an alternative exists. After a suspect drug is stopped, the guideline’s approach is to watch and wait^[2].

Anabolic steroids and testosterone

Anabolic steroids are a well-known trigger. At one academic center, 11% of 964 men who had gynecomastia surgery reported past steroid use, and those men needed repeat surgery more often (3.8% vs 1.1%)^[12]. Testosterone itself is an androgen that aromatase can convert to estradiol^[9], and hCG is on the list of definite causes^[11]. Low testosterone from failing testes or pituitary signaling can cause gynecomastia too^[3]. The guideline’s position: testosterone treatment should be offered only to men with proven deficiency^[2]. For how testosterone therapy is monitored, including estradiol, see our TRT and fat-loss review.

How a clinician tells chest fat from gynecomastia

There’s no reliable at-home test, and a chest that looks the same in the mirror can be fat, gland, or both. The distinction is made on examination. In true gynecomastia, a solid mass of tissue can typically be felt under the nipple and areola, and palpation should be able to separate fatty from glandular tissue^[3]. The European Academy of Andrology guideline lays out what a proper evaluation includes^[2]:

• History: when the enlargement started and how long it has lasted, sexual development and function, and any medications, supplements, or steroids^[2].
• Breast exam: to confirm whether gland tissue is present (as opposed to fat) and to look for anything suspicious for cancer^[2].
• Testicular exam, often with ultrasound: to check for testicular atrophy or a tumor, since palpation alone misses many testicular tumors^[2].
• Blood tests where warranted: testosterone, estradiol, SHBG, LH, FSH, TSH, prolactin, hCG, AFP, and liver and kidney function^[2].
• Imaging only when the exam is unclear, and a core-needle biopsy if a lesion looks suspicious^[2].

A primary care clinician can do the first screen — ruling out simple fat, obvious cancer, or a testicular tumor — with specialist referral when a fuller workup is needed^[2].

What weight loss can — and can’t — do

If it’s chest fat, losing overall body fat is the treatment. Chest fat is ordinary body fat, and it shrinks as overall fat does. Any method that produces sustained fat loss works — diet, activity, and, for men who qualify, GLP-1 medications such as semaglutide or tirzepatide, which reduce chest fat through the same fat loss that shrinks breasts in women (see why breasts shrink on GLP-1s). A GLP-1 is a fat-loss tool, not a gynecomastia treatment. After large losses, some men are left with loose skin rather than fat; what helps loose skin is a separate question.

If it’s gland tissue, weight loss removes the fat around it — which can make the chest look smaller — and, in theory, less body fat means less aromatase-driven estrogen^[9]. But gland tissue remodels and becomes irreversibly fibrous within 12 months at most. A clinical review puts it plainly: “This fibrous tissue cannot be removed conservatively”^[3]. Accordingly, the guideline pathways for established gynecomastia run through finding the cause, waiting, medication in selected cases, and surgery — not diet alone^[2][6].

Can chest exercises spot-reduce man boobs?

Not in any meaningful way. The idea that working a muscle burns the fat on top of it — “spot reduction” — has been tested directly. In a study of 104 adults who trained only one arm for 12 weeks, MRI showed subcutaneous fat loss that was body-wide, not concentrated in the trained arm. Skinfold calipers hinted at a local effect in men, but the more precise MRI did not confirm it^[4].

The evidence isn’t entirely one-sided. A small 2023 randomized trial in 16 overweight men compared running alone with running plus abdominal exercise at matched energy expenditure. Over 10 weeks, the abdominal-exercise group lost about 700 g more trunk fat, while total fat loss was similar between groups^[5]. That’s a modest local effect in one small study, on the abdomen — not a way to melt chest fat, and irrelevant to gland tissue.

Chest training is still worth doing. It builds the pectoral muscle underneath, which changes the shape of the chest, and resistance training helps you keep muscle while you lose fat — see strength training during weight loss.

Medication: where tamoxifen fits

The first medical step is usually not a drug. It’s treating an underlying condition, or stopping a causative substance, and then waiting^[2]. Beyond that, guidelines disagree. The European Academy of Andrology does not recommend selective estrogen receptor modulators (such as tamoxifen), aromatase inhibitors, or non-aromatizable androgens for gynecomastia in general — a strong recommendation based on low-quality evidence^[2]. The 2026 Italian guideline is more permissive: drug therapy “may be considered in selected idiopathic or painful forms”^[6].

Why the split? The data are thin. Tamoxifen has been reported to shrink gynecomastia in up to 80% of patients, but those results come from “few studies with very small case numbers.” The aromatase inhibitor anastrozole did no better than placebo in boys with pubertal gynecomastia^[3]. The strongest evidence comes from a specific group: men taking anti-androgen drugs for prostate cancer. There, a systematic review of randomized trials found tamoxifen cut the risk of gynecomastia at six months by about 90% compared with no treatment (risk ratio 0.10, 95% CI 0.05 to 0.22) and cut breast pain by a similar margin (RR 0.06)^[13]. Tamoxifen’s FDA-labeled uses are all breast-cancer treatment and risk reduction; gynecomastia isn’t among them, so using it for this purpose is off-label^[14].

Timing matters. Medication has a chance while the gland is still active — recent, sometimes tender tissue. Once it has turned fibrous, after about a year, there’s little left for a drug to act on^[3]. If your enlargement is new and painful, whether a trial of medication makes sense is a question for an endocrinologist or urologist. It isn’t something to self-treat with gray-market pills.

Surgery: the definitive fix for long-standing gynecomastia

For gynecomastia that has persisted and not regressed on its own or with medical therapy, the European guideline suggests surgery. The extent and type depend on how large the breast is and how much fat it contains^[2] — which is where the fat-versus-gland distinction becomes practical. Liposuction removes fat; the gland itself usually has to be removed surgically. A systematic review found that surgical excision of the gland combined with liposuction gave the most consistent results with a low complication rate, while noting that every included study was non-randomized, with very low certainty of evidence^[15]. The Italian guideline also supports surgery for long-standing fibrous gynecomastia or significant psychological distress^[6]. Men with a history of steroid use should know their revision rate was higher in the large surgical series above^[12].

When to see a doctor promptly

• A distinct lump, nipple discharge, nipple distortion, or enlargement on one side only. In these cases “malignancy is a possibility,” and urgent referral to a breast clinic is advised^[1].
• New breast growth as an adult. An underlying cause is found in roughly half of adult cases, including medications and testicular problems^[2].

Keep the cancer risk in proportion. Gynecomastia is not a premalignant condition^[2]. Male breast cancer accounts for less than 1% of all breast cancers. It typically shows up as a lump under the nipple, nipple changes, or pain, often in older men, and inherited BRCA2 variants are the main genetic risk factor^[7]. Rare means worth checking, not worth ignoring.

A practical plan

1. Get examined first. Whether you have fat, gland, or both determines everything else, and a clinical exam can usually tell^[3].
2. If it’s fat, treat the fat. Aim for sustained overall fat loss. Train your chest for shape, not for fat burning.
3. If it’s gland and recent, work with a clinician to find and remove any cause — medications, steroids, hormone problems — then give it time. Ask whether medication is reasonable if it’s painful^[2][6].
4. If it’s gland and has been there more than a year, expect that diet and drugs won’t remove it. Surgery is the treatment of choice^[3][15].

The most useful thing to know: if you lose weight and a firm mass of tissue stays behind your nipple, you haven’t failed at dieting. That is most likely gland tissue, which fat loss was never going to remove — get it examined, because it has its own set of answers.